• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受新辅助放化疗和手术治疗的直肠腺癌中,病理变量具有预后意义吗?

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?

作者信息

Reggiani Bonetti Luca, Lionti Simona, Domati Federica, Barresi Valeria

机构信息

Luca Reggiani Bonetti, Federica Domati, Department of Laboratory Integrated Activities, Anatomic Pathology and Legal Medicine, Section of Pathology, University of Modena and Reggio Emilia, 41124 Modena, Italy.

出版信息

World J Gastroenterol. 2017 Feb 28;23(8):1412-1423. doi: 10.3748/wjg.v23.i8.1412.

DOI:10.3748/wjg.v23.i8.1412
PMID:28293088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5330826/
Abstract

AIM

To clarify which factors may influence pathological tumor response and affect clinical outcomes in patients with locally advanced rectal carcinoma treated with neo-adjuvant chemoradiotherapy and surgery.

METHODS

Tumor regression grade (TRG) according to the Dworak system and yTNM stage were assessed and correlated with pre-treatment clinico-pathological variables in 215 clinically locally advanced (cTNM stage II and III) rectal carcinomas. Prognostic value of all pathological and clinical factors on disease free survival (DFS) and cancer specific survival (CSS) was analyzed by Kaplan Meier and Cox-regression analyses.

RESULTS

cN+ status, mucinous histotype or poor differentiation in the pre-treatment biopsy were significantly associated with lower pathological response (low Dworak grade and TNM remaining unchanged/upstaging). Cases showing acellular mucin pools in surgical specimens all had unremarkable clinical courses with no deaths or recurrences during follow-up. Dworak grade had prognostic significance for DFS and CSS. However, compared to the 5-tiered system, a simplified two-tiered grading system, in which grades 0, 1 and 2 were grouped as absent/partial regression and grades 3 and 4 were grouped as total/subtotal regression, was more reproducible and prognostically informative. The two-tiered Dworak system, yN stage, craniocaudal extension of the tumor and radial margin status were significant independent prognostic variables.

CONCLUSION

Our data suggest that caution should be applied in using a conservative approach in rectal carcinomas with cN+ status, extensive/lower involvement of the rectum and mucinous histotype or poor differentiation. Although Dworak TRG is prognostically significant, a simplified two-tiered system could be preferable. Finally, cases with acellular mucin pools should be carefully evaluated to definitely exclude residual mucinous carcinoma.

摘要

目的

明确在接受新辅助放化疗及手术治疗的局部晚期直肠癌患者中,哪些因素可能影响肿瘤的病理反应并影响临床结局。

方法

对215例临床局部晚期(cTNM分期为II期和III期)直肠癌患者,根据Dworak系统评估肿瘤退缩分级(TRG)及yTNM分期,并将其与治疗前临床病理变量进行关联分析。通过Kaplan-Meier法和Cox回归分析,分析所有病理和临床因素对无病生存期(DFS)和癌症特异性生存期(CSS)的预后价值。

结果

治疗前活检中cN+状态、黏液组织学类型或低分化与较低的病理反应(低Dworak分级且TNM分期未改变/分期上升)显著相关。手术标本中显示无细胞黏液池的病例,其临床病程均无异常,随访期间无死亡或复发。Dworak分级对DFS和CSS具有预后意义。然而,与五级系统相比,一种简化的两级分级系统(其中0、1和2级归为无/部分退缩,3和4级归为完全/次全退缩)更具可重复性且预后信息更丰富。两级Dworak系统、yN分期、肿瘤的头尾延伸及切缘状态是显著的独立预后变量。

结论

我们的数据表明,对于cN+状态、直肠广泛/低位受累、黏液组织学类型或低分化的直肠癌患者,采用保守治疗方法时应谨慎。尽管Dworak TRG具有预后意义,但简化的两级系统可能更可取。最后,对于有无细胞黏液池的病例,应仔细评估以明确排除残留黏液癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/5e289726ff20/WJG-23-1412-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/5c3b75cbf059/WJG-23-1412-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/fb2240a25bec/WJG-23-1412-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/6ce410eab173/WJG-23-1412-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/41ce2f709592/WJG-23-1412-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/582749b9a7f0/WJG-23-1412-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/22e5988a75b6/WJG-23-1412-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/5e289726ff20/WJG-23-1412-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/5c3b75cbf059/WJG-23-1412-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/fb2240a25bec/WJG-23-1412-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/6ce410eab173/WJG-23-1412-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/41ce2f709592/WJG-23-1412-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/582749b9a7f0/WJG-23-1412-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/22e5988a75b6/WJG-23-1412-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e894/5330826/5e289726ff20/WJG-23-1412-g007.jpg

相似文献

1
Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?在接受新辅助放化疗和手术治疗的直肠腺癌中,病理变量具有预后意义吗?
World J Gastroenterol. 2017 Feb 28;23(8):1412-1423. doi: 10.3748/wjg.v23.i8.1412.
2
Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.基于低分化簇的组织学分级可预测接受新辅助放化疗的直肠癌的肿瘤反应和临床结局。
Histopathology. 2017 Sep;71(3):393-405. doi: 10.1111/his.13242. Epub 2017 Jun 23.
3
Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.接受术前放化疗后行根治性手术的局部晚期黏液性直肠癌患者中细胞性和无细胞黏蛋白的患病率及临床意义
Colorectal Dis. 2016 Jan;18(1):O10-6. doi: 10.1111/codi.13169.
4
Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.新辅助放化疗后局部晚期直肠癌临床及病理分期的预后意义
Radiat Oncol. 2015 Jun 4;10:124. doi: 10.1186/s13014-015-0425-5.
5
Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.新辅助放化疗后肿瘤退缩分级对一组局部晚期直肠癌患者的预后意义:一项为期8年的单机构回顾性研究。
Colorectal Dis. 2017 Jul;19(7):O263-O271. doi: 10.1111/codi.13757.
6
What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?直肠癌患者术前放化疗后的理想肿瘤退缩分级系统是什么?
Cancer Res Treat. 2016 Jul;48(3):998-1009. doi: 10.4143/crt.2015.254. Epub 2015 Oct 22.
7
Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.新辅助治疗后直肠癌淋巴结肿瘤退缩的预后意义
Virchows Arch. 2016 Apr;468(4):425-30. doi: 10.1007/s00428-015-1901-x. Epub 2016 Jan 11.
8
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.新辅助放化疗后直肠癌中无细胞黏蛋白池的意义。
Am J Surg Pathol. 2011 Jan;35(1):127-34. doi: 10.1097/PAS.0b013e318200cf78.
9
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.新辅助放化疗治疗直肠癌后肿瘤退缩分级的预后价值。
Colorectal Dis. 2014 Jan;16(1):O16-25. doi: 10.1111/codi.12439.
10
Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.局部进展期中高位和中低位直肠癌术前放化疗的疗效和安全性比较。
Radiat Oncol. 2018 Mar 27;13(1):53. doi: 10.1186/s13014-018-0987-0.

引用本文的文献

1
Predictors of pathological complete response after total neoadjuvant treatment using short course radiotherapy for locally advanced rectal cancer.局部晚期直肠癌短程放疗全新辅助治疗后病理完全缓解的预测因素
BMC Gastroenterol. 2025 Mar 31;25(1):208. doi: 10.1186/s12876-025-03709-1.
2
Predictors of Pathologic Non-response to Neoadjuvant Approaches in Locally Advanced Rectal Cancer.局部晚期直肠癌新辅助治疗病理无反应的预测因素
Ann Surg Oncol. 2025 May;32(5):3089-3097. doi: 10.1245/s10434-025-16962-1. Epub 2025 Feb 7.
3
Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.

本文引用的文献

1
Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.中国局部晚期直肠癌术前放化疗后美国癌症联合委员会(AJCC)肿瘤退缩分级系统的病理评估
Medicine (Baltimore). 2016 Jan;95(3):e2272. doi: 10.1097/MD.0000000000002272.
2
What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?直肠癌患者术前放化疗后的理想肿瘤退缩分级系统是什么?
Cancer Res Treat. 2016 Jul;48(3):998-1009. doi: 10.4143/crt.2015.254. Epub 2015 Oct 22.
3
Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy.
局部晚期直肠癌新辅助放化疗后病理完全缓解的预测
Front Oncol. 2024 Mar 11;14:1361300. doi: 10.3389/fonc.2024.1361300. eCollection 2024.
4
Tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: influencing factors and prognostic significance.新辅助放化疗后局部晚期直肠癌的肿瘤退缩分级:影响因素及预后意义
Int J Clin Exp Pathol. 2023 Jun 15;16(6):124-132. eCollection 2023.
5
Locally advanced rectal mucinous adenocarcinoma: is preoperative radiation necessary?局部进展期直肠黏液腺癌:术前放疗是否必要?
J Gastrointest Oncol. 2022 Oct;13(5):2366-2374. doi: 10.21037/jgo-22-817.
6
H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma.H3K27me3免疫组化缺失预示直肠癌对新辅助放化疗的反应较低。
Biomedicines. 2022 Aug 21;10(8):2042. doi: 10.3390/biomedicines10082042.
7
Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.循环 miRNA 特征可预测局部晚期直肠癌术前放化疗的反应。
JCO Precis Oncol. 2021 Dec 2;5. doi: 10.1200/PO.21.00015. eCollection 2021.
8
Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.用于预测接受新辅助治疗的直肠癌患者生存率的列线图和风险评分模型。
World J Gastroenterol. 2020 Nov 14;26(42):6638-6657. doi: 10.3748/wjg.v26.i42.6638.
9
A New MRI-Defined Biomarker for Rectal Mucinous Adenocarcinoma: Mucin Pool Patterns in Determining the Efficacy of Neoadjuvant Therapy.一种用于直肠黏液腺癌的新的磁共振成像定义生物标志物:黏液池模式在确定新辅助治疗疗效中的作用
Front Oncol. 2020 Aug 20;10:1425. doi: 10.3389/fonc.2020.01425. eCollection 2020.
10
Radiomics of rectal cancer for predicting distant metastasis and overall survival.用于预测直肠癌远处转移和总生存期的影像组学
World J Gastroenterol. 2020 Sep 7;26(33):5008-5021. doi: 10.3748/wjg.v26.i33.5008.
术前放化疗后直肠癌中细胞性和无细胞性黏蛋白池的临床意义
Clin Transl Oncol. 2016 Jul;18(7):714-21. doi: 10.1007/s12094-015-1422-8. Epub 2015 Oct 16.
4
Rectal cancer resection and circumferential margin rates in Canada: a population-based study.加拿大直肠癌切除术及环周切缘率:一项基于人群的研究。
Curr Oncol. 2015 Feb;22(1):60-3. doi: 10.3747/co.22.2391.
5
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.多模式治疗后局部晚期直肠癌肿瘤退缩分级系统的比较
J Natl Cancer Inst. 2014 Sep 22;106(10). doi: 10.1093/jnci/dju248. Print 2014 Oct.
6
Impact of acellular mucin pools on survival in patients with complete pathological response to neoadjuvant treatment in rectal cancer.无细胞黏蛋白池对直肠癌新辅助治疗完全病理缓解患者生存的影响。
Int J Surg. 2014 Oct;12(10):1123-6. doi: 10.1016/j.ijsu.2014.07.267. Epub 2014 Jul 27.
7
Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.局部晚期直肠癌放化疗后的肿瘤退缩分级:接近病理完全缓解并不意味着良好的临床结局。
Radiother Oncol. 2014 Jul;112(1):44-51. doi: 10.1016/j.radonc.2014.05.010. Epub 2014 Jul 10.
8
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.局部进展期直肠癌术前放化疗后肿瘤退缩分级的再评价:CAO/ARO/AIO-94 研究的更新结果。
J Clin Oncol. 2014 May 20;32(15):1554-62. doi: 10.1200/JCO.2013.54.3769. Epub 2014 Apr 21.
9
Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.新辅助放化疗后完全临床缓解和观察等待的直肠癌局部复发:挽救治疗对局部疾病控制的影响。
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):822-8. doi: 10.1016/j.ijrobp.2013.12.012. Epub 2014 Feb 1.
10
Histopathological regression grading matches excellently with local and regional spread after neoadjuvant therapy of rectal cancer.直肠癌新辅助治疗后,组织病理学消退分级与局部和区域扩散具有极好的吻合性。
Pathol Res Pract. 2013 Jul;209(7):424-8. doi: 10.1016/j.prp.2013.04.009. Epub 2013 Apr 30.